Research and Markets: GSK's Fendrix (Prophylactic Hepatitis B Virus Vaccines) Market 2014- Forecast Opportunities to 2022
GlaxoSmithKline sells oncology portfolio to Novartis for $16B
European stocks rise as AstraZeneca, Glaxo climb
Update on GSK ’S MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Non-Small Cell Lung Cancer
ADR Shares End Mixed; RBS Shares Active
Our top managers continue to focus on higher-quality businesses rather than seeking out bargains in a market that (in many of their minds) has become fully valued.
UPDATE: FTSE rises for second day as miners push higher
FTSE rises for second day as miners push higher
Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.
NetScientific Partners with Peter Thiel’s Breakout Labs to Increase Support for Companies at the Forefront of Scientific Innovation